Skip to main content

Reducing Mortality in the Perioperative Period: A Continuous Update

  • Chapter
  • First Online:
  • 728 Accesses

Abstract

According to the EUSOS study, perioperative mortality for noncardiac surgery is 1–4 % [1], considering that up to 230 million surgical procedures are performed each year in the world [2], even a small reduction would have a tremendous impact on public health.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Pearse RM, Moreno RP, Bauer P et al (2012) Mortality after surgery in Europe: a 7 day cohort study. Lancet 380:1059–1065

    Article  PubMed  PubMed Central  Google Scholar 

  2. Weiser TG, Regenbogen SE, Thompson KD et al (2008) An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet 372:139–144

    Article  PubMed  Google Scholar 

  3. Landoni G, Rodseth RN, Santini F et al (2012) Randomized evidence for reduction of perioperative mortality. J Cardiothorac Vasc Anesth 26(5):764–772. pii: S1053-0770(16)30281–6. doi:10.1053/j.jvca.2016.07.017. [Epub ahead of print]

  4. Landoni G, Pisano A, Lomivorotov V et al (2016) Randomized evidence for reduction of perioperative mortality: an updated consensus process. J Cardiothorac Vasc Anesth. 2016 Aug 2. pii: S1053-0770(16)30281-6. doi: 10.1053/j.jvca.2016.07.017. [Epub ahead of print]

    Google Scholar 

  5. Kowalewski M, Pawliszak W, Raffa GM et al (2015) Safety and efficacy of miniaturized extracorporeal circulation when compared with off-pump and conventional coronary artery bypass grafting: evidence synthesis from a comprehensive Bayesian-framework network meta-analysis of 134 randomized controlled trials involving 22 778 patients. Eur J Cardiothorac Surg 49:1428–40

    Google Scholar 

  6. Belletti A, Musu M, Silvetti S et al (2015) Non-adrenergic vasopressors in patients with or at risk for vasodilatory shock. A systematic review and meta-analysis of randomized trials. PLoS ONE 10:e0142605

    Article  PubMed  PubMed Central  Google Scholar 

  7. Ripollés-Melchor J, Espinosa Á, Martínez-Hurtado E et al (2016) Perioperative goal-directed hemodynamic therapy in noncardiac surgery: a systematic review and meta-analysis. J Clin Anesth 28:105–115

    Article  PubMed  Google Scholar 

  8. Zangrillo A, Musu M, Greco T et al (2015) Additive effect on survival of anaesthetic cardiac protection and remote ischemic preconditioning in cardiac surgery: a Bayesian network meta-analysis of randomized trials. PLoS ONE 10:e0134264

    Article  PubMed  PubMed Central  Google Scholar 

  9. Poirier Y, Voisine P, Plourde G et al (2016) Efficacy and safety of preoperative intra-aortic balloon pump use in patients undergoing cardiac surgery: a systematic review and meta-analysis. Int J Cardiol 207:67–79

    Article  PubMed  Google Scholar 

  10. Pilarczyk K, Boening A, Jakob H et al (2016) Preoperative intra-aortic counterpulsation in high-risk patients undergoing cardiac surgery: a meta-analysis of randomized controlled trials. Eur J Cardiothorac Surg 49:5–17

    Article  PubMed  Google Scholar 

  11. Zhou C, Gong J, Chen D et al (2016) Levosimendan for prevention of acute kidney injury after cardiac surgery: a meta-analysis of randomized controlled trials. Am J Kidney Dis 67:408–416

    Article  CAS  PubMed  Google Scholar 

  12. Qiao L, Xu C, Li X, Li F, Liu W (2015) Heart calcium sensitizer on morbidity and mortality of high-risk surgical patients with MODS: systematic review and meta-analysis. Int J Clin Exp Med 8:17712–17720

    PubMed  PubMed Central  Google Scholar 

  13. Le Page S, Bejan-Angoulvant T, Angoulvant D, Prunier F (2015) Remote ischemic conditioning and cardioprotection: a systematic review and meta-analysis of randomized clinical trials. Basic Res Cardiol 110:11

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marta Mucchetti .

Editor information

Editors and Affiliations

Summary of the New Evidences

Summary of the New Evidences

New topic

Intervention

Author

Control

Setting

N of RCT

N of patients

Size effect

Notes

Yes

Miniaturized extracorporeal circulation

Kowalewski M

Conventional extracorporeal circulation

CABG

134

22,778

OR 0.46 (95 % CI 0.22–0.91)

Network meta- analysis, comparing also off-pump CABG

Vasopressin, terlipressin or methylene blue

Belletti A

Placebo or norepinephrine or dopamine or standard treatment

Vasodilatatory shock (cardiac surgery/critically ill (sepsis))

20

1,608

RR 0.88 (95 % CI 0.79–0.98)

Multiple comparators

Mixed population

Perioperative goal-directed hemodynamic therapy

Ripollés-Melchor J

Conventional fluid therapy

Noncardiac surgery

10

1,527

RR 0.63 (95 % CI 0.42–0.94)

 

No

Volatile agents

Zangrillo A

TIVA

CCH

55

6,921

OR 0.56 (95 % CI 0.36–0.88)

Network meta-analysis (volatile, TIVA ± RIPC). Significant effect in direct comparison for volatile vs TIVA (36 studies, 3,680 patients)

Preoperative IABP

Poirier Y

No intervention

CCH

11

1,293

OR 0.20 (95 % CI 0.09–0.44)

Observational studies were included, but were analyzed separately

Pilarczyk K

No intervention

CCH

9

1,171

OR 0.38 (95 % CI 0.23–0.63)

 

Levosimendan

Zhou C

Placebo or dobutamine or milrinone

CCH

13

1,254

OR 0.43 (95 % CI 0.25–0.76)

Multiple comparators

Qiao L

Placebo or dobutamine or milrinone

CABG(high-risk surgical patients)

10

440

OR 0.35 (95 % CI 0.18–0.71)

Multiple comparators

Remote ischemic preconditioning

Le Page S

No intervention

CCH and interventional cardiology

44

5,317

OR 0.27 (95 % CI 0.13–0.58)

Mixed population. Long -term mortality was reported only in three RCTs (383 patients)

  1. 95 % CI 95 % confidence interval, CABG coronary artery bypass graft, CCH cardiac surgery, IABP intra-aortic balloon pump, N number, OR odd ratio, RCT randomized controlled trial, RIPC remote ischemic preconditioning, RR relative risk, TIVA total intravenous anesthesia

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Mucchetti, M., Landoni, G. (2017). Reducing Mortality in the Perioperative Period: A Continuous Update. In: Landoni, G., Ruggeri, L., Zangrillo, A. (eds) Reducing Mortality in the Perioperative Period. Springer, Cham. https://doi.org/10.1007/978-3-319-46696-5_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-46696-5_18

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-46695-8

  • Online ISBN: 978-3-319-46696-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics